• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Attention Deficit Disorder with Hyperactivity

Attention Deficit Disorder with Hyperactivity - 737 Studies Found

Completed : TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
: Attention Deficit Disorder With Hyperactivity
: 2014-03-07
:
  • Drug: TRI102 formulation conta

Completed : Cognitive Behavior Group Therapy in Adolescents With Attention Deficit Hyperactivity Disorder
: Attention Deficit Disorder With Hyperactivity
: 2016-10-14
:
  • Behavioral: cognitive behavior group therapy

Completed : Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type
: Attention Deficit Disorder With Hyperactivity
: 2016-08-31
: Behavioral: Cognitive-behavioral therapy
Completed : A Functional Outcomes Study With Atomoxetine-Hydrochloride and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder
: Attention Deficit Disorder With Hyperactivity
: 2005-09-12
:
  • Drug: Atomoxetine Hydrochloride
  • Drug: plac

Completed : Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
: Attention Deficit Disorder With Hyperactivity
: 2016-06-15
: Drug: mazindol
Completed : Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17
: Attention Deficit Disorder With Hyperactivity
: 2005-09-07
:
  • Drug: SPD503 (Guanfacine hydrochloride) (2 mg)

Completed : Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)
: Attention Deficit Disorder With Hyperactivity
: 2005-09-07
:
  • Drug: Methylphenidate + SPD503 (Guanfacine hydrochloride)

Completed : Efficacy of Atomoxetine on Psychosocial Function of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
: Attention Deficit Disorder With Hyperactivity
: 2006-04-28
: Drug: atomoxetine 0.5 milligrams per kilogram per day (mg/kg/day), by mouth (PO) for 1 week then 1.2 mg/
Completed : Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
: Attention Deficit Disorder With Hyperactivity
: 2009-06-29
:
  • Drug: OROS MPH Optimal Patient

Completed : Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
: Attention Deficit Disorder With Hyperactivity
: 2006-10-06
:
  • Drug: atomoxetine
  • Drug: placebo

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.